Skip to Main Content
ADVERTISEMENT
SCROLL TO CONTINUE WITH CONTENT



Property Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes
Advertisement
Journal of Lipid Research
Open access logo
Close
  • Home
  • Articles & Volumes
    • Back
    • Papers in Press
    • Current Volume
    • List of Volumes
  • For Authors
    • Back
    • Information for Authors
    • Permission to Reuse Published Material
    • Submit Manuscript 
  • Journal Info
    • Back
    • 2023 Media Kit 
    • About Open Access 
    • About the Journal
    • Contact Information
    • Editorial Board 
    • New Content Alerts
  • Special collections
  • Images in Lipid Research
  • Virtual Issues
  • Thematic Reviews
  • Methods Papers
  • Commentaries
  • Patient Oriented
  • Regular Research Articles
  • Other ASBMB Publications
    • Back
    • Journal of Biological Chemistry
    • Molecular & Cellular Proteomics
    • ASBMB Today 
Advanced searchSave search

Please enter a term before submitting your search.

Ok
  • Submit
  • Log in
  • Register
  • Log in
    • Submit
    • Log in
Skip menu
    x

    Filter:

    Filters applied

    • Regular Research Articles
    • triacylglycerolRemove triacylglycerol filter
    • NAFLDRemove NAFLD filter
    Clear all

    Article Type

    • Research Article3

    Publication Date

    • Last Year1
    • Last 2 Years1
    • Last 5 Years3
    Please choose a date range between 2021 and 2022.

    Author

    • Abernathy, Breann E1
    • Ackerman, Jacobo Miranda1
    • Anand, Sumit Kumar1
    • Andersson, Emma1
    • Barrow, Fanta1
    • Blüher, Matthias1
    • Brosch, Mario1
    • Buch, Stephan1
    • Cansby, Emmelie1
    • Caputo, Mara1
    • Coskun, Ünal1
    • Cui, Wenqi1
    • Desai, Arnav S1
    • Fredrickson, Gavin1
    • Gross, Justus1
    • Hampe, Jochen1
    • Hartler, Jürgen1
    • Has, Canan1
    • Henricsson, Marcus1
    • Höög, Johanna Louise1
    • Keuenhof, Katharina Susanne1
    • Klipp, Edda1
    • Knittelfelder, Oskar1
    • Kumari, Sima1
    • Köfeler, Harald C1

    Journal

    • Journal of Lipid Research3

    Keyword

    • CE2
    • NASH2
    • 4-HNE1
    • 4-hydroxynonenal1
    • ACC1
    • ALT1
    • AP1
    • AST1
    • AUC1
    • C/EBP-homologous protein1
    • Cer1
    • Chol1
    • CHOP1
    • DCFDA1
    • DE1
    • DG1
    • ECAR1
    • ER1
    • ERK1
    • FFA1
    • FPC1
    • GFAP1
    • GGT1

    Access Filter

    • Open Access

    Regular Research Articles

    3 Results
    Subscribe to collection
    • Export
      • PDF
      • Citation

    Please select at least one article in order to proceed.

    Ok
    FilterHide Filter
    • Research Article
      Open Access

      Inhibition of MAP4K4 signaling initiates metabolic reprogramming to protect hepatocytes from lipotoxic damage

      Journal of Lipid Research
      Vol. 63Issue 7100238Published online: June 6, 2022
      • Sumit Kumar Anand
      • Mara Caputo
      • Ying Xia
      • Emma Andersson
      • Emmelie Cansby
      • Sima Kumari
      • and others
      Cited in Scopus: 1
      • Preview Hide Preview
      • Download PDF
      • Export Citation
        The primary hepatic consequence of obesity is non-alcoholic fatty liver disease (NAFLD), affecting about 25% of the global adult population. Non-alcoholic steatohepatitis (NASH) is a severe form of NAFLD characterized by liver lipid accumulation, inflammation, and hepatocyte ballooning, with a different degree of hepatic fibrosis. In the light of rapidly increasing prevalence of NAFLD and NASH, there is an urgent need for improved understanding of the molecular pathogenesis of these diseases. The aim of this study was to decipher the possible role of STE20-type kinase MAP4K4 in the regulation of hepatocellular lipotoxicity and susceptibility to NAFLD.
        Inhibition of MAP4K4 signaling initiates metabolic reprogramming to protect hepatocytes from lipotoxic damage
      • Research Article
        Open Access

        Nonalcoholic fatty liver disease stratification by liver lipidomics

        Journal of Lipid Research
        Vol. 62100104Published online: August 9, 2021
        • Olga Vvedenskaya
        • Tim Daniel Rose
        • Oskar Knittelfelder
        • Alessandra Palladini
        • Judith Andrea Heidrun Wodke
        • Kai Schuhmann
        • and others
        Cited in Scopus: 18
        • Preview Hide Preview
        • Download PDF
        • Export Citation
          Nonalcoholic fatty liver disease (NAFLD) is a common metabolic dysfunction leading to hepatic steatosis. However, NAFLD's global impact on the liver lipidome is poorly understood. Using high-resolution shotgun mass spectrometry, we quantified the molar abundance of 316 species from 22 major lipid classes in liver biopsies of 365 patients, including nonsteatotic patients with normal or excessive weight, patients diagnosed with NAFL (nonalcoholic fatty liver) or NASH (nonalcoholic steatohepatitis), and patients bearing common mutations of NAFLD-related protein factors.
          Nonalcoholic fatty liver disease stratification by liver lipidomics
        • Research Article
          Open Access

          Hepatic lysosomal acid lipase overexpression worsens hepatic inflammation in mice fed a Western diet

          Journal of Lipid Research
          Vol. 62100133Published online: October 5, 2021
          • Michael W. Lopresti
          • Wenqi Cui
          • Breann E. Abernathy
          • Gavin Fredrickson
          • Fanta Barrow
          • Arnav S. Desai
          • and others
          Cited in Scopus: 0
          • Preview Hide Preview
          • Download PDF
          • Export Citation
            Nonalcoholic fatty liver disease (NAFLD) is characterized by the accumulation of lipid droplets in hepatocytes. NAFLD development and progression is associated with an increase in hepatic cholesterol levels and decreased autophagy and lipophagy flux. Previous studies have shown that the expression of lysosomal acid lipase (LAL), encoded by the gene LIPA, which can hydrolyze both triglyceride and cholesteryl esters, is inversely correlated with the severity of NAFLD. In addition, ablation of LAL activity results in profound NAFLD.
            Hepatic lysosomal acid lipase overexpression worsens hepatic inflammation in mice fed a Western diet
          Page 1 of 1

          Login to your account

          Show
          Forgot password?
          Don’t have an account?
          Create a Free Account

          If you don't remember your password, you can reset it by entering your email address and clicking the Reset Password button. You will then receive an email that contains a secure link for resetting your password

          If the address matches a valid account an email will be sent to __email__ with instructions for resetting your password

          Cancel
          • Home
          • Articles & Volumes
          • Papers in Press
          • Current Volume
          • List of Volumes
          • For Authors
          • Information for Authors
          • Permissions
          • Submit Manuscript
          • Contact Us
          • Contact Information
          • Journal Info
          • 2023 Media Kit
          • Open Access
          • About the Journal
          • Editorial Board
          • New Content Alerts
          • Special collections
          • Images in Lipid Research
          • Virtual Issues
          • Thematic Reviews
          • Methods Papers
          • Commentaries
          • Patient Oriented
          • Regular Research Articles
          • Other ASBMB Publications
          • Journal of Biological Chemistry
          • Molecular & Cellular Proteomics
          • ASBMB Today

          ASBMB  ASBMB  ASBMB  ASBMB

          ISSN 0022-2275
          We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the for this site.
          Copyright © 2022 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.

          • Privacy Policy  
          • Terms and Conditions  
          • Accessibility  
          • Elsevier Help & Contact

          RELX